Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Prepaid Assets (2017 - 2025)

Historic Prepaid Assets for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to $3.1 million.

  • Cue Biopharma's Prepaid Assets rose 8491.69% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 8491.69%. This contributed to the annual value of $805000.0 for FY2024, which is 1570.68% down from last year.
  • Latest data reveals that Cue Biopharma reported Prepaid Assets of $3.1 million as of Q3 2025, which was up 8491.69% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Cue Biopharma's Prepaid Assets registered a high of $3.9 million during Q2 2021, and its lowest value of $805000.0 during Q4 2024.
  • Over the past 5 years, Cue Biopharma's median Prepaid Assets value was $1.9 million (recorded in 2023), while the average stood at $1.9 million.
  • Per our database at Business Quant, Cue Biopharma's Prepaid Assets crashed by 4440.7% in 2022 and then surged by 8491.69% in 2025.
  • Over the past 5 years, Cue Biopharma's Prepaid Assets (Quarter) stood at $954792.0 in 2021, then dropped by 11.92% to $841000.0 in 2022, then rose by 13.56% to $955000.0 in 2023, then decreased by 15.71% to $805000.0 in 2024, then surged by 286.83% to $3.1 million in 2025.
  • Its Prepaid Assets stands at $3.1 million for Q3 2025, versus $2.4 million for Q2 2025 and $1.9 million for Q1 2025.